Abbott/Millennium Metabolic Disease Deal Aims For 4-5 Drugs In 10 Years
Executive Summary
Abbott expects to bring four to five obesity and diabetes drugs to the market in the next 10 years under an alliance announced with Millennium Pharmaceuticals.